BY1023/NL511
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BY1023/NL511, covering 2012-05-07 to 2012-05-07. Get the full timeline:
Most recent: Clinical Trial Update: The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511) [Phase 4]